安非雷古林
生物
再生(生物学)
过继性细胞移植
细胞生物学
胸腺细胞
间质细胞
免疫学
T细胞
癌症研究
免疫系统
癌症
遗传学
表皮生长因子受体
作者
Andri L. Lemarquis,Anastasia I. Kousa,Kimon V. Argyropoulos,Lorenz Jahn,Brianna Gipson,Jonah Pierce,Lucia Serrano-Marin,Kristen Victor,Yuzuka Kanno,Narina N. Girotra,Hana Andrlová,Jennifer J. Tsai,Enrico Velardi,Roshan Sharma,Simon Grassmann,Olov Ekwall,Andrew B. Goldstone,Jarrod A. Dudakov,Susan DeWolf,Marcel R.M. van den Brink
出处
期刊:Immunity
[Cell Press]
日期:2025-01-31
卷期号:58 (2): 397-411.e6
被引量:1
标识
DOI:10.1016/j.immuni.2025.01.006
摘要
Thymic injury associated with disease or cancer treatment reduces T cell production and makes patients more vulnerable to infections and cancers. Here, we examined the role of regulatory T (Treg) cells on thymic regeneration. Treg cell frequencies increased in the thymus in various acute injury models. Depletion of Treg cells impaired thymic regeneration, impacting both the thymocyte compartment and the stromal cell compartment; adoptive transfer of Treg cells enhanced regeneration. Expansion of circulating Treg cells, as opposed to that of tissue resident or recent thymic emigrants, explained this increase, as seen using parabiotic and adoptive transfer models. Single-cell analyses of recirculating Treg cells revealed expression of various regenerative factors, including the cytokine amphiregulin. Deletion of amphiregulin in these Treg cells impaired regeneration in the injured thymus. We identified an analogous population of CD39+ICOS+ Treg cells in the human thymus. Our findings point to potential therapeutic avenues to address aging- and treatment-induced immunosuppression.
科研通智能强力驱动
Strongly Powered by AbleSci AI